Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile-associated Diarrhea (CDAD)”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableWithdrawnNCT01596153
What this trial is testing

Probiotics in Hospitalized Patients Study

Who this might be right for
Antibiotic Associated DiarrheaClostridium Difficile Associated Diarrhea
South Shore Hospital
Large-scale testing (Phase 3)Study completedNCT01598311
What this trial is testing

CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 608
Testing effectiveness (Phase 2)Study completedNCT01222702
What this trial is testing

Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile Infection
Actelion 84
Not applicableUnknownNCT02681068
What this trial is testing

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation

Who this might be right for
Clostridium Infections
University of Cologne 1,000
Large-scale testing (Phase 3)Study completedNCT00958308
What this trial is testing

Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection

Who this might be right for
Antibiotic-Associated DiarrheaClostridium Difficile-Associated Diarrhea
Bio-K Plus International Inc. 255
Not applicableStudy completedNCT01401023
What this trial is testing

Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

Who this might be right for
DiarrheaClostridium Difficile
Gary E. Stein, Pharm.D. 10
Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Testing effectiveness (Phase 2)Study completedNCT03824795
What this trial is testing

Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

Who this might be right for
Clostridium Difficile Infection
MGB Biopharma Limited 34
Testing effectiveness (Phase 2)Study completedNCT00034294
What this trial is testing

GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Clostridium Difficile-Associated DiarrheaClostridium EnterocolitisClostridium Difficile Diarrhea+2 more
Genzyme, a Sanofi Company 300
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Large-scale testing (Phase 3)Study completedNCT01983683
What this trial is testing

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium Difficile Infection
Actelion 631
Large-scale testing (Phase 3)Study completedNCT00196794
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisDiarrhea
Genzyme, a Sanofi Company 520
Testing effectiveness (Phase 2)Study completedNCT02092935
What this trial is testing

SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)

Who this might be right for
Clostridium Difficile Infection
Summit Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Large-scale testing (Phase 3)Study completedNCT00106509
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisPseudomembranous Colitis
Genzyme, a Sanofi Company 520
Large-scale testing (Phase 3)Ended earlyNCT03105479
What this trial is testing

Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile Infection
Actelion 1
Large-scale testing (Phase 3)Study completedNCT00182429
What this trial is testing

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

Who this might be right for
Clostridium EnterocolitisAntibiotic-Associated DiarrheaPseudomembranous Colitis+2 more
McMaster University 100
Large-scale testing (Phase 3)Study completedNCT00468728
What this trial is testing

PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 535
Early research (Phase 1)Study completedNCT02835118
What this trial is testing

Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 30
Not applicableUnknownNCT03141775
What this trial is testing

Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Diarrhea
University of Cologne 541
Next Page